Pharma is investing heavily in AI-driven CRM and 'next-best-action' tools, but engagement quality hasn’t kept pace. This is a capability gap, not a technology gap. We set out why human judgement is the scarce advantage, and introduce HAISEM: a model for harmonising AI and human capability across the engagement cycle.

Together with BluePath Health, we recently brought together a small group of cross-sector health leaders in New York for an intimate dinner salon to tackle a shared challenge: why adoption in healthcare still moves too slowly, even when innovation is strong. The conversation centered on what decision-ready evidence really looks like, and how tools like clinical simulation and data sandboxes can help teams learn faster, reduce risk earlier, and move from evidence to action.